McKesson Ventures highlights investment priorities amidst a trail of successful exits
McKesson Ventures is one of the most active investors in the biopharma software sector with Komodo Health, Evidation and M2Gen among its portfolio companies.
McKesson Ventures is one of the most active investors in the biopharma software sector with Komodo Health, Evidation and M2Gen among its portfolio companies.
M2Gen, which has been around since 2006, and Moffitt are part of the Oncology Research Information Exchange Network alliance, which has 17 cancer center members that have access to a data warehouse linking clinical and molecular data.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.